Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

We explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce ove

Original research | 2022
About PWUD, Harm reduction, Decriminalization/legalization, Stigma, Illegal drugs
Letter | 2022
About PWUD, Policy/Regulatory, Equity, Advocacy

To assess for long-term positive effects of buprenorphine treatment (BT) on opioid use disorder (OUD) at a Nishnawbe Aski Nation high school clinic

Original research | 2020
Indigenous, Youth, Substitution/OAT, About PWUD

Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Original research | 2023
About PWUD, Clinical guidance

Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other drug use.

Original research | 2023
About PWUD, Substitution/OAT, Barriers and enablers

Drawing on data from U.S.

Original research | 2023
Mortality, Overdose, About PWUD, Policy/Regulatory

This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency d

Original research | 2023
Mortality, About PWUD

This study estimated cost savings from expanding access to substance use disorder (SUD) treatment for persons with opioid use disorders (OUD).

Original research | 2023
Policy/Regulatory

The aim of this study was to examine what drives increases in opioid overdose death among Black Americans based on the experience of key stakeholders.

Original research | 2023
Equity, Overdose, Mortality

Take-Home Naloxone (THN) kits may be stored in non-standard conditions, including in vehicles, backpacks, and out of doors.

Original research | 2019
Harm reduction, Overdose

This paper builds upon the concept of the ‘informed patient’ to explore individuals’ decisions to initiate injectable depot buprenorphine.

Original research | 2023
About PWUD, Substitution/OAT, Transitions in care/treatment, Barriers and enablers
Page Web | 2023
les services enveloppants
Webpage | 2023
Wrap-around services
Page Web | 2023
la réduction des méfaits, les services enveloppants
Webpage | 2023
Harm reduction, Wrap-around services
Page Web | 2022
les services enveloppants, participation de personnes ayant une expérience vivante ou vécue
Webpage | 2022
Wrap-around services, Peer/PWLLE program involvement

Researchers have argued that providing genetic explanations of addiction will reduce stigma, but there has been limited research testing this prediction.

Original research | 2023
Stigma

Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers.

Original research | 2023
Harm reduction, Barriers and enablers, Drug checking, Illegal drugs, Peer/PWLLE program involvement

The present study aimed to investigate the effect of zinc supplementation on the probability of relapse (PoR) and mental health (MH) problems in patients with opioid use disorder undergoing MMT.

Original research | 2023
Substitution/OAT, Mental health

Affiner votre recherche

Mots clés
Format
Région